Outline of the history of drug synthesis with particular emphasis on anticancer and antibacterial drugs
DOI:
https://doi.org/10.56782/pps.121Keywords:
synthesis, antibacterial drugs, anticancer drugsAbstract
The paper presents a historical outline of the development of drugs from the earliest times to the present, trying to take into account the path that has come from learning about the medicinal properties of the raw material, through the identification of specific active compounds isolated from it, to the identification of a biological target. On the example of the synthesis of the first chemical medicaments, the research directions and reasoning of the scientists of that time were indicated. By discussing the history of antimicrobials, the pathway from Fleming's accidental discovery to the organic synthesis of compounds with non-antimicrobial biological activity was outlined. This fact overlaps with the history of the development of anti-cancer drugs, which was discussed in terms of the main mechanisms of action.
Downloads
References
Brzeziński, T.; Historia medycyny, Wyd. II; Wydawnictwo Lekarskie PZWL, Warszawa, Polska, 1995; ISBN 83-200-184-3.
Jesus, A.; Bonhomme, V.; Evin, A.; Ivorra, S.; Soteras, R.; Salavert, A.; Antolín, F.; Bouby L. A morphometric approach to track opium poppy domestication. Sci. Rep. 2021, 11, Art. No. 9778. https://doi.org/10.1038/s41598-021-88964-4. DOI: https://doi.org/10.1038/s41598-021-88964-4
Legrain, L. Royal Inscriptions and Fragments from Nippur and Babylon. The Museum of the University of Pennsylvania 1926, XV.
Arabas, I. Z dziejów aptekarstwa. Czy Galen był aptekarzem? Aptekarz Polski 2011, 61/39, 46–49.
Widelski, J. Medycyna arabska. Aptekarz Polski 2009, 36/14. Available online: https://www.aptekarzpolski.pl/wiedza/08-2009-mak-lekarski-i-opium/ (accessed on 13.10.2022).
Borucka, M. Wybrane osiągnięcia cywilizacji arabsko-muzułmańskiej. NURT SVD, 2013, Wydanie specjalne 2013, 85-91.
Szumowski, W. Historia medycyny filozoficznie ujęta, 1st. ed.; Wydawnictwo Marek Derewecki, Kraków, Polska, 1935.
Stawarz, N. Alchemia: klucz do wszechwiedzy. Available online: https://histmag.org/Alchemia-klucz-do-wszechwiedzy-18940 (accessed on 13.10.2022).
Małecka, E. Zanim pojawiła się chemia. Available online: http://docplayer.pl/10767070-Zanim-pojawila-sie-chemia.html (accessed on 13.10.2022).
Favier, J. Wielkie odkrycia od Aleksandra do Magellana, 1st ed.; Oficyna Wydawnicza Volumen, Warszawa, Polska, 1996.
Boyle, R. The Sceptical Chymist; 1st ed., J. Caldwell, Londyn, Anglia, 1661.
Jędrusiak, M. Kilka słów o flogistonie, czyli o tym, jak błędna teoria przyniosła nauce wiele pożytku. Available online: http://www.deltami.edu.pl/temat/roznosci/historia_i_filozofia/2016/12/27/Kilka_slow_o_flogistonie/ (accessed on 13.10.2022).
Carl-Wilhelm-Scheele. Available online: https://www.britannica.com/biography/Carl-Wilhelm-Scheele (accessed on 13.10.2022).
Marggraf Andreas Sigismund. Available online: https://encyklopedia.pwn.pl/haslo/Marggraf-Andreas-Sigismund;3937731.html (accessed on 13.10.2022).
Krishnamurti, C.; Chakra Rao SSC, The isolation of morphine by Serturner. Indian J. Anaesth. 2016, 60 (11), 861–862. DOI: https://doi.org/10.4103/0019-5049.193696
Friedrich C., von Domarus C. Carl Friedrich Wilhelm Meissner (1792–1853) – Apotheker und Alkaloidforscher. Die Pharmazie 1998, 53, 67–73.
Leung, A.M.; Braverman, L.E.; Pearce, E.N. History of U.S. Iodine Fortification and Supplementation, Nutrients 2012, 4 (11), 1740–1746. doi: 10.3390/nu4111740. DOI: https://doi.org/10.3390/nu4111740
Abel, A. The history of dyes and pigments: from natural dyes to high performance pigments. In COLOUR DESIGN: THEORIES AND APPLICATIONS, 2nd ed.; Best, J. Eds.; Woodhead Publishing, Sawston, Wielka Brytania, 2012; pp. 557-587. DOI: https://doi.org/10.1016/B978-0-08-101270-3.00024-2
Kinne-Saffran, E.; Kinne, R.K. Vitalism and synthesis of urea. From Friedrich Wöhler to Hans A. Krebs. Am. J. Nephrol. 1999, 19 (2), 290-294. doi: 10.1159/000013463. DOI: https://doi.org/10.1159/000013463
van den Belt, H. Why Monopoly Failed: The Rise and Fall of Société La Fuchsie. Br. J. Hist. Sci. 1992, 25 (1), 45-63. DOI: https://doi.org/10.1017/S0007087400045325
Caro, H. XVII. On the formation of rosolic acid and rosaniline. Lond. Edinb. Dublin Philos. Mag. J. Sci. 1866, 4 (32), 126-132. https://doi.org/10.1080/14786446608644138. DOI: https://doi.org/10.1080/14786446608644138
Corbeil, M-C.; Charland, J-P.; Moffatt, E.A. The Characterization of Cobalt Violet Pigments. Stud. Conserv. 2002, 47 (4), 237-249. DOI: https://doi.org/10.1179/sic.2002.47.4.237
Kirimura, K.; Gunji, H.; Wakayama, R.; Hattori, T.; Ishii, Y. Enzymatic Kolbe-Schmitt reaction to form salicylic acid from phenol: enzymatic characterization and gene identification of a novel enzyme, Trichosporon moniliiforme salicylic acid decarboxylase. Biochem. Biophys. Res. Commun. 2010, 394 (2), 279-284. doi: 10.1016/j.bbrc.2010.02.154. DOI: https://doi.org/10.1016/j.bbrc.2010.02.154
Smith, P.W.G.; Tatchell A.R. Phenols In Aromatic Chemistry: Organic Chemistry for General Degree Students, 1st. ed., Pergamon, Oxford, Wielka Brytania, 1969; pp. 79-104. DOI: https://doi.org/10.1016/B978-0-08-012948-8.50008-5
Marson, P.; Pasero, G. The Italian contributions to the history of salicylates. Reumatismo 2006, 8 (1), 66-75. doi: 10.4081/reumatismo.2006.66. DOI: https://doi.org/10.4081/reumatismo.2006.66
Sneader, W. The discovery of aspirin: a reappraisal. BMJ 2000, 32 (7276), 1591–1594. doi: 10.1136/bmj.321.7276.1591. DOI: https://doi.org/10.1136/bmj.321.7276.1591
Rinsema, T.J. One Hundred Years of Aspiryn. Med. Hist. 1999, 43, 502-507. DOI: https://doi.org/10.1017/S0025727300065728
Renslo, A.R. Antimalarial Drug Discovery: From Quinine to the Dream of Eradication. ACS Med. Chem. Lett. 2013, 4 (12), 1126-1128. doi: 10.1021/ml4004414. DOI: https://doi.org/10.1021/ml4004414
Greenwood, D. The quinine connection. J. Antimicrob. Chemother. 1992, 30 (4), 417-427. doi: 10.1093/jac/30.4.417 DOI: https://doi.org/10.1093/jac/30.4.417
Schweitzer, H. The Influence of Sir William Henry Perkin's Discovery Upon Our Science. Science 1906, 24 (6), 481-488. DOI: https://doi.org/10.1126/science.24.616.481
Podlewski, J.K.; Chwalibogowska-Podlewska, A. Leki współczesnej terapii, 17 ed.; Split Trading, Warszawa, Polska, 2005. ISBN 83-85632-82-4.
Schultz, M.P. The use of amidopiryne in rheumatic fever. Arch Intern Med (Chic) 1931, 48 (6), 1138-1155. doi:10.1001/archinte.1931.00150070076006. DOI: https://doi.org/10.1001/archinte.1931.00150070076006
Otterness, I.G. The Discovery of Drugs to Treat Arthritis: A Historical View In The Search for Anti-Inflammatory Drugs, Merluzzi, V.J., Adams, J. Eds.; Birkhäuser, Szwajcaria, 2012, pp. 1-26. DOI: https://doi.org/10.1007/978-1-4615-9846-6_1
Petermann, H.; Goerig, M. History of anesthesia: From narcosis to perioperative homeostasis. Anaesthesist 2016, 65 (10), 787-808. doi: 10.1007/s00101-016-0223-y. DOI: https://doi.org/10.1007/s00101-016-0223-y
Robinson, D.H.; Toledo, A.H. Historical development of modern anesthesia. J. Invest. Surg. 2012, 25 (3), 141-149. doi: 10.3109/08941939.2012.690328. DOI: https://doi.org/10.3109/08941939.2012.690328
Butler, T.C. The introduction of chloral hydrate into medical practice. Bull. Hist. Med., 1970, 44 (2), 168-172.
Johnson, A.S. Paraldehyde for the Control of Pain and Convulsive States. N. Engl. J. Med. 1934, 210, 1065-1067. doi: 10.1056/NEJM193405172102005. DOI: https://doi.org/10.1056/NEJM193405172102005
Maruta, H. From chemotherapy to signal therapy (1909-2009): A century pioneered by Paul Ehrlich. Drug Discov. Ther. 2009, 3 (2), 37-40.
Gelpi, A.; Gilbertson, A.; Tucker, J.D. Magic bullet: Paul Ehrlich, Salvarsan and the birth of venereology. Sex. Transm. Infect. 2015, 91 (1), 68–69. doi: 10.1136/sextrans-2014-051779. DOI: https://doi.org/10.1136/sextrans-2014-051779
Farmacja Współczesna, Nr 3, Warszawa, 1938 r. online: https://jbc.bj.uj.edu.pl/Content/325241/PDF/NDIGCZAS013803_1938.pdf (accessed on 17.10.2022)
Marriott, H.L. Sulphapyridine And Pneumococcal Infections. Br. Med. J. 1939, 2 (4114), 944-947. DOI: https://doi.org/10.1136/bmj.2.4114.944
Rouf, A.; Tanyeli, C. Bioactive thiazole and benzothiazole derivatives, Eur. J. Med. Chem. 2015, 97, 911-927. doi:10.1016/j.ejmech.2014.10.058. DOI: https://doi.org/10.1016/j.ejmech.2014.10.058
Smyth, C.J.; Finkelstein, M.B.; Gould, S.E.; Koppa, M.D.; Leeder, F.S. Acute Bacillary Dysentery (Flexner): Treatment with Sulfaguanidine and Succinylsulfathiazole. J. Am. Med. Ass. 1943, 121 (17), 1325–1330. doi:10.1001/jama.1943.02840170009003. DOI: https://doi.org/10.1001/jama.1943.02840170009003
Potty, V.H.; Tamhane, D.V. Action of Sulfanilamide on Ochromonas malhamensis, J. Protozoology 1968, 15 (2), 262-268. https://doi.org/10.1111/j.1550-7408.1968.tb02120.x. DOI: https://doi.org/10.1111/j.1550-7408.1968.tb02120.x
Tan, S.Y.; Tatsumura, Y. Alexander Fleming (1881–1955): Discoverer of penicillin. Singapore Med J. 2015, 56 (7), 366–367. doi: 10.11622/smedj.2015105. DOI: https://doi.org/10.11622/smedj.2015105
Lobanovska, M.; Pilla, G. Penicillin’s Discovery and Antibiotic Resistance: Lessons for the Future? Yale J. Biol. Med. 2017, 90 (1), 135–145.
Ory, E.M; Meads, M.; Finland, M. Penicillin x: comparison with penicillin G with respect to sensitivity of pathogenic organism and serum level. JAMA 1945, 129 (4), 257-261. doi:10.1001/jama.1945.02860380015004. DOI: https://doi.org/10.1001/jama.1945.02860380015004
Oral Administration of Penicillin. N. Engl. J. Med. 1955, 253, 789-790. doi: 10.1056/NEJM195511032531811. DOI: https://doi.org/10.1056/NEJM195511032531811
Batchelor, F.R.; Doyle, F.P.; Nayler, J.H.C.; Rolinson, G.N. 6-Aminopenicillanic Acid in Penicillin Fermentations. Nature 1959, 183, 257–258. DOI: https://doi.org/10.1038/183257b0
Streptomycin. Available online: https://www.britannica.com/science/streptomycin (accessed on 09.11.2021).
Ehrlich, J.; Gottlieb, D.; Burkholder, P.R.; Anderson, L.E.; Pridham, T.G. Streptomyces venezuelae, n. sp., the source of chloromycetin. J. Bacteriol. 1948, 56 (4), 467-477. doi: 10.1128/jb.56.4.467-477.1948. DOI: https://doi.org/10.1128/jb.56.4.467-477.1948
Duggar, B.M. Aureomycin; a product of the continuing search for new antibiotics, Ann. N. Y. Acad. Sci. 1948, 51 (Art. 2), 177-181. doi: 10.1111/j.1749-6632.1948.tb27262.x. DOI: https://doi.org/10.1111/j.1749-6632.1948.tb27262.x
Boothe, J.H.; Morton, J.; Petisi, J.P.; Wilkinson, R.G.; Williams, J.H. Tetracycline. J. Am. Chem. Soc. 1953, 75 (18), 4621. https://doi.org/10.1021/ja01114a535. DOI: https://doi.org/10.1021/ja01114a535
Finlay, A.C.; Hobby, G.L.; P'an, S.Y.; Regna, P.P.; Routien, J.B.; Seeley, D.B.; Shull, G.M.; Sobin, B.A.; Solomons, I.A.; Vinson, J.W.; Kane, J.H. Terramycin, a new antibiotic. Science 1950, 111 (2874), 85. doi: 10.1126/science.111.2874.85. DOI: https://doi.org/10.1126/science.111.2874.85-a
Harned, R.L.; Hidy, P.H.; La Baw, E.K. Cycloserine. I. A preliminary report, Antibiot. Chemother. (Northfield), 1955, 5 (4), 204-205.
Umezawa, H.; Ueda, M.; Maeda, K.; Yagishita, K.; Kondō, S.; Okami, Y.; Utahara, R.; Ōsato, Y.; Nitta, K.; Takeuchi, T. Production and isolation of a new antibiotic: kanamycin. J Antibiot (Tokyo) 1957, 10 (5), 181-188.
Weinstein, M.J.; Leudemann, G.M.; Oden, E.M.; Wagman, G.H. Gentamycin, a new broad-spectrum antibiotic complex. Antimicrob. Agents Chemother. (Bethesda) 1963, 161, 1-7.
Umezawa, H.; Takeuchtti, T.; Nitta, K.; Yamamoto, T.; Yamakoka, S. Sarkomycin, an anti-tumor substance produced by streptomyces. J. Antibiot. (Tokyo) 1953, 6 (2), 101.
Bo, G. Giuseppe Brotzu and the discovery of cephalosporins. CMI Clin. Microbiol. Infect. 2000, 6 (3), 6-8. DOI: https://doi.org/10.1111/j.1469-0691.2000.tb02032.x
Lodger, B.; Newton, G.G.; Abraham, E.P. The cephalosporin C nucleus (7-aminocephalosporanic acid) and some of its derivatives. Biochem. J. 1961, 79 (2), 408-416. doi: 10.1042/bj0790408. DOI: https://doi.org/10.1042/bj0790408
Kahan, J.S.; Kahan, F.M.; Goegelman, R.; Currie, S.A.; Jackson, M.; Stapley, E.O.; Miller, T.W.; Miller, A.K.; Hendlin, D.; Mochales, S.; Hernandez, S.; Woodruff, H.B.; Birnbaum, J. Thienamycin, a new beta-lactam antibiotic. 1. Discovery, taxonomy, isolation ad physical properties. J. Antibiot. 1979, 32 (1), 1-12. DOI: https://doi.org/10.7164/antibiotics.32.1
Hotchkiss, R.D.; Dubos, R. Bactericidal fractions from an aerobic sporulating bacillus. J. Biol. Chem. 1940, 136 (3), 803–804. DOI: https://doi.org/10.1016/S0021-9258(18)73041-X
Waksman, S.A.; Geiger, W.B.; Reynolds, D.M. Strain Specificity and Production of Antibiotic Substances: VII. Production of Actinomycin by Different Actinomycetes. Proc. Natl. Acad. Sci. USA. 1946, 32 (5), 117-120. doi: 10.1073/pnas.32.5.117. DOI: https://doi.org/10.1073/pnas.32.5.117
Bagnicka, E.; Jóźwik, A.; Strzałkowska, N.; Krzyżewski J.; Zwierzchowski, L. Antimicrobial peptides - outline of the history of studies and mode of action. Medycyna Weterynaryjna – Vet. Med-Sci Prac. 2011, 67 (7), 444-448.
Habermann, E.; Reiz, K.G. On the biochemistry of bee venom peptides, melittin and apamin. Biochem. Z. 1965, 343 (2), 192-203.
Akari, K.; Tachibana, S.; Uchiyama, M.; Nakajima, T.; Yasuhara, T. Isolation and Structure of a New Active Peptide Xenopsin on Rat Stomach Strip and Some Biogenic Amines in the Skin of Xenopus laevis. Chem. Pharm. Bull. 1975, 23 (12), 3132-3140. https://doi.org/10.1248/cpb.23.3132. DOI: https://doi.org/10.1248/cpb.23.3132
Hultmark, D.; Engström, A.; Bennich, H.; Kapur, R.; Boman, H.G. Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae. Eur. J. Biochem. 1982, 127 (1), 207-217. doi: 10.1111/j.1432-1033.1982.tb06857.x. DOI: https://doi.org/10.1111/j.1432-1033.1982.tb06857.x
Neomycin. Available online: https://www.britannica.com/science/neomycin (accessed on 10.11.2021)
Weinstein, M.J.; Marquez, J.A.; Testa, R.T.; Wagman, G.H.; Oden, E.M.; Waitz, J.A. Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic. J. Antibiot. 1970, 23 (11), 551–554. doi:10.7164/antibiotics.23.551. DOI: https://doi.org/10.7164/antibiotics.23.551
Fischer, J.; Ganellin, C.R. Analogue-based Drug Discovery; John Wiley & Sons, 2006. pp. 507. ISBN 9783527607495. DOI: https://doi.org/10.1002/3527608001
Doxycycline. Available online: https://go.drugbank.com/drugs/DB00254 (accessed on 13.10.2022).
Shukla, S.J.; Sakamuru, S.; Huang, R.; Moeller, T.A.; Shinn, P.; Vanleer, D.; Auld, D.S.; Austin, C.P.; Xia, M. Identification of clinically used drugs that activate pregnane X receptors. Drug Metab. Dispos. 2011, 39 (1), 151–159. DOI: https://doi.org/10.1124/dmd.110.035105
Patent US 2653899. Bunch R.L.; Mcguire J.M. Erythromycin, its salts, and method of preparation, Eli Lilly and Company.
Jelic, D.; Antolovic, R. From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials. Antibiotics (Basel) 2016, 5 (3), Art. No. 29. doi: 10.3390/antibiotics5030029. DOI: https://doi.org/10.3390/antibiotics5030029
Puri, S.K.; Lassman, H.B. Roxithromycin: a pharmacokinetic review of a macrolide. J. Antimicrob. Chemother. 1987, 20 Suppl B, 89-100. doi: 10.1093/jac/20.suppl_b.89. DOI: https://doi.org/10.1093/jac/20.suppl_B.89
Greenwood, D. Antimicrobial drugs: chronicle of a twentieth century medical triumph, 1 ed., Oxford University Press, Oxford, pp. 239. ISBN 9780199534845.
Mac Load, A.J.; Ross, H.B.; Ozere, R.L.; Digout, G.; van Rooyen, C.E. Lincomycin: A New Antibiotic Active Against Staphylococci and Other Gram-Positive Cocci: Clinical and Laboratory Studies. Can. Med. Assoc. J., 1964, 91, 1056–1960.
Smieja, M. Current indications for the use of clindamycin: A critical review. Can. J. Infect. Dis. 1998, 9 (1), 22–28. doi: 10.1155/1998/538090. DOI: https://doi.org/10.1155/1998/538090
Hall, T.C. Chemotherapy of Cancer. N. Engl. J. Med. 1962, 266, 129-134. doi: 10.1056/NEJM196201182660306. DOI: https://doi.org/10.1056/NEJM196201182660306
The Science Behind Radiation Therapy. Available online: https://www.cancer.org/content/dam/CRC/PDF/Public/6151.00.pdf (accessed on 13.10.2022).
Radium - a key element in early cancer treatment. Available online: https://www.rsc.org/images/Dronsfield_tcm18-200827.pdf (accessed on 13.11.2022).
Bonadonna, G. Does chemotherapy fulfill its expectations in cancer treatment? Ann. Oncol. 1990, 1 (1), 11-21. doi: 10.1093/oxfordjournals.annonc.a057665. DOI: https://doi.org/10.1093/oxfordjournals.annonc.a057665
Colvin, M. Alkylating Agents In Holland-Frei Cancer Medicine. 6th ed.; Kufe, D.W., Pollock, R.E., Weichselbaum, R.R., Bast, R.C.Jr., Gansler, T.S., Holland, J.F., Frei, E., Eds.; Hamilton (ON): BC Decker; Ontario, Kanada, 2003.
Goldman, R.; Egeberg, R.O.; Ware, E.R.; Evans, E.R.; Fishkin, B.G., Clinical experience with nitrogen mustard therapy. Arch. Intern. Med. (Chic) 1948, 82 (2), 125-139. doi: 10.1001/archinte.1948.00220260015002. DOI: https://doi.org/10.1001/archinte.1948.00220260015002
Spurr, C.L.; Smoth, T.R.; Block, M.; Jacobson, L.O. The role of nitrogen mustard therapy in the treatment of lymphomas and leukemias. Am. J. Med. 1950, 8 (6), 710-723. https://doi.org/10.1016/0002-9343(50)90095-7. DOI: https://doi.org/10.1016/0002-9343(50)90095-7
Goodman, J.; Walsh, V. The Story of Taxol: Nature and Politics in the Pursuit of an Anti-Cancer Drug, Cambridge University Press, Wielka Brytania, 2001. ISBN 978-0-521-56123-5.
Taxol® (NSC 125973). Available online: https://dtp.cancer.gov/timeline/flash/success_stories/s2_taxol.htm (accessed on 13.10.2022)
Malik, S.; Cusidó, R.M.; Mirjalili, M.H.; Moyano, E.; Palazón, J.; Bonfil, M. Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review. Proc. Biochem. 2011, 46 (1), 23-34. https://doi.org/10.1016/j.procbio.2010.09.004. DOI: https://doi.org/10.1016/j.procbio.2010.09.004
Talebi, M.; Ghassempour, A.; Talebpour, Z.; Rassouli, A.; Dolatyari, L. Optimization of the extraction of paclitaxel from Taxus baccata L. by the use of microwave energy. J. Sep. Sci. 2004, 27 (13), 1130-1136. doi: 10.1002/jssc.200401754. DOI: https://doi.org/10.1002/jssc.200401754
van Hoesel, Q.G.C.M.; Verweij, J.; Catimel, G.; Clavel, M.; Kerbrat, P.; van Oosterom, A.T.; Kerger, J.; Tursz, T.; van Glabbeke, M.; van Pottelsberghe, C.; le Bail, N.; Mouridsen, H. Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult. Ann. Oncol. 1994, 5, 539-542. DOI: https://doi.org/10.1093/oxfordjournals.annonc.a058909
Lavelle, F.; Gueritte-Voegelein, F.; Guenard, D. Taxotere: from yew's needles to clinical practice. Bull. Cancer 1993, 80 (4), 326-338.
Noble, R.L.; Beer, C.T.; Cutts, J.H. Role of chance observations in chemotherapy: Vinca rosea. Ann NY Acad Sci 1958, 76, 882-894. DOI: https://doi.org/10.1111/j.1749-6632.1958.tb54906.x
Svoboda, G.H.; Neuss, N.; Gorman, M. Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.) V. Preparation and characterization of alkaloids. J. Am. Pharm. Ass. 1959, 48 (11), 659-666. https://doi.org/10.1002/jps.3030481115. DOI: https://doi.org/10.1002/jps.3030481115
Wall, M.E.; Wani, M.C.; Cook, C.E.; Palmer, K.H.; McPhail, A.T.; Sim, G.A. Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminate. J. Am. Chem. Soc. 1966, 88 (16), 3888–3890. https://doi.org/10.1021/ja00968a057. DOI: https://doi.org/10.1021/ja00968a057
Di Marco, A.; Gaetani, M.; Dorigotti, L; Soldati, M.; Bellini, O. Daunomycin: A New Antibiotic with Antitumor Activity. Tumori J. 1963, 49 (3), 203-217. https://doi.org/10.1177/030089166304900305. DOI: https://doi.org/10.1177/030089166304900305
Wang, J.C. Interaction between DNA and an Escherichia coli protein omega. J. Mol. Biol. 1971, 55 (3), 523-533. doi: 10.1016/0022-2836(71)90334-2. DOI: https://doi.org/10.1016/0022-2836(71)90334-2
Gellert, M.; O'Dea, M.H.; Itoh, T.; Tomizawa, J. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc. Natl. Acad. Sci. USA. 1976, 73 (12), 4474-4478. doi: 10.1073/pnas.73.12.4474. DOI: https://doi.org/10.1073/pnas.73.12.4474
Mastrangelo, S.; Attina, G.; Triarico, S.; Romano, A.; Maurizi, P.; Ruggiero, A. The DNA-topoisomerase Inhibitors in Cancer Therapy. Biomed. Pharmacol. J. 2022, 15 (2), 553-562. DOI: https://doi.org/10.13005/bpj/2396
Hata, T.; Hoshi, T.; Kanamori, K.; Matsumae, A.; Sano, Y.; Shima, T.; Sugawara, R. Mitomycin, a new antibiotic from Streptomyces. I. J. Antibiot. (Tokyo) 1956, 9 (4), 141-146.
Umezawa, H.; Maeda, K.; Takeuchi, T.; Okami, Y. New antibiotics, bleomycin A and B. J. Antibiot. (Tokyo) 1966, 19 (5), 200-209.
Dubost, M.; Ganter, P.; Maral, R.; Ninet, L.; Pinnert, S.; Preudhomme, J.; Werner, G.H. Rubidomycin: a new antibiotic with cytostatic properties. C R Hebd Seances Acad. Sci. 1963, 257, 1813-1815.
Daunorubicin. Available online: https://go.drugbank.com/drugs/DB00694 (accessed on 17.10.2022)
Nakano, I.; Soe, C.Z.; Codd, R. Isolation of doxorubicin from a bacterial culture using immobilised metal ion affinity chromatography. RSC Advances, 2015, 5(58), 46437-46442. DOI: https://doi.org/10.1039/C5RA07639K
Bonfante, V.; Bonadonna, G.; Villani, F.; Mrtini, A. Preliminary clinical experience with 4-epidoxorubicin in advanced human neoplasia. Rec. Res. Cancer Res. 1980, 74, 192-199. doi:10.1007/978-3-642-81488-4_24. DOI: https://doi.org/10.1007/978-3-642-81488-4_24
Buckley, M.M.; Lamb, H.M. Oral idarubicin. A review of its pharmacological properties and clinical efficacy in the treatment of haematological malignancies and advanced breast cancer. Drugs Aging 1997, 11 (1), 61-86. doi: 10.2165/00002512-199711010-0000. DOI: https://doi.org/10.2165/00002512-199711010-00006
White, R.J.; Durr, F.E. Development of mitoxantrone. Invest. New Drugs 1985, 3 (2), 85-93. doi: 10.1007/BF00174154. DOI: https://doi.org/10.1007/BF00174154
Farber, S.; Diamond, L.K.; Mercer, R.D.; Sylvester, R.F. Jr.; Wolff, J.A. Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin). N. Engl. J. Med. 1948, 238, 787-793. doi: 10.1056/NEJM194806032382301. DOI: https://doi.org/10.1056/NEJM194806032382301
Weinblatt, M.E. Methotrexate in Rheumatoid Arthritis: A Quarter Century of Development. Trans. Am. Clin. Climatol. Assoc. 2013, 124, 16–25.
Huennekens, F.M. The methotrexate story: a paradigm for development of cancer chemotherapeutic agents. Adv. Enzyme Regul. 1994, 34, 397-419. doi: 10.1016/0065-2571(94)90025-6. DOI: https://doi.org/10.1016/0065-2571(94)90025-6
Manegold, C. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma. Semin. Oncol. 2003, 30 (4 Suppl 10), 32–36. doi:10.1016/S0093-7754(03)00283-5. DOI: https://doi.org/10.1016/S0093-7754(03)00283-5
Rossi, A.; Ricciardi, S.; Maione, P.; de Marinis, F.; Gridelli, C. Pemetrexed in the treatment of advanced non-squamous lung cancer. Lung Cancer 2009, 66 (2), 141–149. doi:10.1016/j.lungcan.2009.06.006. DOI: https://doi.org/10.1016/j.lungcan.2009.06.006
Vardanyan, R.; Hruby, V. Immunopharmacological Drugs In Synthesis of Best-Seller Drugs, 1st ed., Academic Press, USA, 2016, pp. 549-572. DOI: https://doi.org/10.1016/B978-0-12-411492-0.00029-8
Antimetabolites for Cancer: Effects, Benefits, Risks. Available online: https://www.webmd.com/cancer/antimetabolite-medications-overview (accessed on 10.11.2021).
Schwartz, R.; Stack, J.; Dameshek, W. Effect of 6-mercaptopurine on antibody production. Proc. Soc. Exp. Biol. Med. 1958, 99 (1), 164–167. doi:10.3181/00379727-99-24281. DOI: https://doi.org/10.3181/00379727-99-24281
Calne, R.Y. The rejection of renal homografts. The Lancet 1960, 275 (7121), 417–418. doi:10.1016/S0140-6736(60)90343-3. DOI: https://doi.org/10.1016/S0140-6736(60)90343-3
Elion, G. The purine path to chemotherapy. Science 1989, 244 (4900), 41–47. doi:10.1126/science.2649979. DOI: https://doi.org/10.1126/science.2649979
Patel, A.A.; Swerlick, R.A.; McCall, C.O. Azathioprine in dermatology. The past, the present, and the future. J. Am. Acad. Dermatol. 2006, 55 (3), 369–389. doi:10.1016/j.jaad.2005.07.059. DOI: https://doi.org/10.1016/j.jaad.2005.07.059
Chemical structure of DNA discovered. Available online: https://www.history.com/this-day-in-history/watson-and-crick-discover-chemical-structure-of-dna (accessed on 14.10.2022).
The Discovery of the Double Helix, 1951-1953. Available online: https://profiles.nlm.nih.gov/spotlight/sc/feature/doublehelix (accessed on 14.10.2022).
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Joanna Warguła

This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.